Women in STEM are at a disadvantage at every stage of the academic pipeline and in almost every facet of their careers. Graduate student Veronica Busa reflects on how these statistics motivate her to focus her efforts.
Perspectives in Research
Distributing Vaccines: Smallpox and the History of Vaccine Campaigns
Posted by | Perspectives in ResearchThe COVID-19 vaccine campaign will last for months, if not longer — it took over a hundred years for vaccination to wipe out smallpox. By examining how smallpox vaccination succeeded and failed, we can learn what may happen with the COVID-19 vaccine rollout and how to address potential pitfalls.
Citation Bias? In My Publication? Here’s How to Check
Posted by | Events and Happenings, Perspectives in ResearchAlthough the makeup of academia and journal authors is becoming more diverse, the under-citation of women and authors of color is worsening. Here are some tools to check your manuscript.
The P-value of People
Posted by | Perspectives in ResearchThe prospect of helping patients is what attracted neuroscience graduate student Riley Bannon to the field of research, but this semester brought many humbling reminders that it is all too easy to lose sight of the bigger, human picture in translational research.
A New and Improved Poster Design
Posted by | Perspectives in ResearchA new poster format that debuted last year claims to improve communication efficacy at scientific conferences. Stephanie Yang weighs in on her experiences with the format.
To Regrow Neurons, Fish Retinas Go Back in Time
Posted by | Perspectives in ResearchHave you ever wondered why worms and fish can regenerate lost limbs while humans can’t? Read how Seth Blackshaw’s developmental neuroscience lab uses insights from zebrafish to regrow damaged eye neurons in mice.
Foghorn Therapeutics Breaks New Ground in Cancer Epigenetics
Posted by | Perspectives in ResearchEpigenetic drugs are an emerging class of cancer therapeutics. In this article, Ph.D. candidate Roshan Chikarmane introduces Foghorn Therapeutics, its co-founder, Cigall Kadoch, and the science behind their drug development program.
COVID-19 Healthcare Disruption and Potentially Unreported STIs
Posted by | Perspectives in ResearchThe COVID-19 pandemic has impacted healthcare systems in many ways beyond direct care of COVID-19 patients. One disruption lies in the public health infrastructure for reporting of infectious diseases, such as sexually transmitted infections (STIs).
Vaccine Season in Full Swing
Posted by | Perspectives in ResearchWith cold and flu season fast approaching, the push to vaccinate communities against influenza is greater than ever. Meanwhile, COVID-19 vaccine trials are working furiously to release a winning candidate by the end of the year.
Genetic Modification, Then and Now
Posted by | Perspectives in ResearchJosh Popp, a second-year biomedical engineering Ph.D. student, discusses how today’s genetically modified foods compare with the plants we’ve been farming for thousands of years.